Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases

[1] Koppe MJ(2006)Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies Annals Surg 243 212-1550

[2] Boerman OC(2002)Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 1545-363

[3] Oyen WJ(2000)Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358-105

[4] Bleichrodt RP(2014)Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry Int J Clin Oncol 19 98-178

[5] Jayne D(2018)Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 25 173-240

[6] Fook S(1995)Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer World J Surg 19 235-3743

[7] Loi C(2003)Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737-3292

[8] Seow-Choen F(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284-2432

[9] Sadeghi B(2008)8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2426-835

[10] Arvieux C(2008)Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg 248 829-685

[1] Koppe MJ(2006)Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies Annals Surg 243 212-1550

[2] Boerman OC(2002)Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 1545-363

[3] Oyen WJ(2000)Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358-105

[4] Bleichrodt RP(2014)Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry Int J Clin Oncol 19 98-178

[5] Jayne D(2018)Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 25 173-240

[6] Fook S(1995)Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer World J Surg 19 235-3743

[7] Loi C(2003)Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737-3292

[8] Seow-Choen F(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284-2432

[9] Sadeghi B(2008)8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2426-835

[10] Arvieux C(2008)Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg 248 829-685